XML 124 R110.htm IDEA: XBRL DOCUMENT v3.20.4
Parent Company Only (Schedule of Condensed Cash Flow Statement) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Condensed Financial Statements, Captions [Line Items]                              
Net income $ 5,172 $ 4,977 $ 252 $ 2,634 $ 2,714 $ 3,058 $ 3,002 $ 2,802 $ 2,847 $ 2,863 $ 2,768 $ 2,528 $ 13,035 $ 11,576 $ 11,006
Stock-based compensation expense                         1,077 817 749
Deferred income tax (benefit) expense                         (87) 341 1,019
Gain on sale of investment securities                             (44)
Net cash provided by operating activities                         296 25,786 13,650
Proceeds from sales of investment securities                         123,459 10,952 13,514
Net cash acquired in acquisition                         53,004    
Net cash used in investing activities                         (164,243) (33,996) (117,119)
Exercise of stock options                             14
Withholdings to purchase capital stock                         219 175 149
Cash paid in lieu of fractional shares                         (4)    
Net cash provided by financing activities                         217,630 6,388 105,129
Net increase (decrease) in cash and cash equivalents                         53,683 (1,822) 1,660
Cash and cash equivalents, beginning       15,663       17,485       15,825 15,663 17,485 15,825
Cash and cash equivalents, ending 69,346       15,663       17,485       69,346 15,663 17,485
Parent Company [Member]                              
Condensed Financial Statements, Captions [Line Items]                              
Net income                         13,035 11,576 11,006
Equity in earnings of subsidiary                         (15,312) (12,876) (11,996)
Stock-based compensation expense                         1,077 817 749
Deferred income tax (benefit) expense                         (84) 2 (60)
Gain on sale of investment securities                             (44)
Changes in other assets and liabilities, net                         71 137 12
Net cash provided by operating activities                         (1,213) (344) (333)
Dividends received from subsidiary                         5,378 4,037 2,723
Proceeds from sales of investment securities                             871
Operating dividend from subsidiary                         1,129    
Net cash acquired in acquisition                         58    
Net cash used in investing activities                         6,565 4,037 3,594
Dividends paid, net of dividends reinvested                         (5,378) (4,037) (3,397)
Exercise of stock options                             14
Withholdings to purchase capital stock                         219 175 149
Net cash provided by financing activities                         (5,159) (3,862) (3,234)
Net increase (decrease) in cash and cash equivalents                         193 (169) 27
Cash and cash equivalents, beginning       $ 63       $ 232       $ 205 63 232 205
Cash and cash equivalents, ending $ 256       $ 63       $ 232       $ 256 $ 63 $ 232